Mona Bhatti

发表

Effects of dabigatran on the cellular and protein phase of coagulation in patients with coronary artery disease on dual antiplatelet therapy with aspirin and clopidogrel

D. Angiolillo, F. Franchi, F. Rollini, 2015, Thrombosis and Haemostasis.

Cigarette Smoking and Antiplatelet Effects of Aspirin Monotherapy Versus Clopidogrel Monotherapy in Patients with Atherosclerotic Disease: Results of a Prospective Pharmacodynamic Study

D. Angiolillo, F. Franchi, F. Rollini, 2014, Journal of Cardiovascular Translational Research.

Pharmacodynamic Effects of Ticagrelor Dosing Regimens in Patients on Maintenance Ticagrelor Therapy: Results From a Prospective, Randomized, Double-Blind Investigation.

D. Angiolillo, F. Franchi, F. Rollini, 2015, JACC. Cardiovascular interventions.

A head-to-head pharmacodynamic comparison of prasugrel vs. ticagrelor after switching from clopidogrel in patients with coronary artery disease: results of a prospective randomized study.

D. Angiolillo, F. Franchi, F. Rollini, 2016, European heart journal.

Impact of Escalating Loading Dose Regimens of Ticagrelor in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: Results of a Prospective Randomized Pharmacokinetic and Pharmacodynamic Investigation.

D. Angiolillo, F. Franchi, F. Rollini, 2015, JACC. Cardiovascular interventions.

Role of thromboelastography and rapid thromboelastography to assess the pharmacodynamic effects of vitamin K antagonists

D. Angiolillo, F. Franchi, F. Rollini, 2015, Journal of Thrombosis and Thrombolysis.

Impact of timing from blood sampling to pharmacodynamic assessment on measures of platelet reactivity in patients treated with P2Y12 receptor inhibitors

D. Angiolillo, F. Franchi, F. Rollini, 2016, Thrombosis and Haemostasis.

Impact of chronic kidney disease on platelet P2Y12 receptor signalling in patients with type 2 diabetes mellitus

D. Angiolillo, F. Rollini, T. Bass, 2016, Thrombosis and Haemostasis.

A head-to-head pharmacodynamic comparison of prasugrel vs. ticagrelor after switching from clopidogrel in patients with coronary artery disease: results of a prospective randomized study.

D. Angiolillo, F. Rollini, Luis A. Guzmán, 2016, European heart journal.